Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials (FACTOR)

This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.

Study Overview

• Status: Recruiting
• Conditions: Cancer
• Intervention / Treatment: Other: Social Determinants of Health Questionnaire

Detailed Description

It is anticipated that 1000 people will take part in this study. Participation in this study will only take about 10 minutes or less. Participants who choose to take part in this study will be asked to fill out a form with questions in English or French about the non-medical factors that influence health. This includes asking about the conditions and places in which the participant lives, learns, works, and plays. Participants will also be asked how they feel about answering these questions. Researchers will use this information to better understand who participates in clinical trials.

• Study Type: Observational
• Enrollment (Estimated): 1000

Contacts and Locations

• Study Contact: Name: Mariam Jafri; Phone Number: 613-533-6430; Email: mjafri@ctg.queensu.ca
• Study Contact Backup: Name: Anna Johnson; Phone Number: 613-533-6430; Email: ajohnson@ctg.queensu.ca

Study Locations

• Canada
  • Alberta
    • Calgary, Alberta, Canada, T2N 5G2
      • Recruiting
      • Arthur J.E. Child Comprehensive Cancer Centre
      • Contact: Marc Kerba; Phone Number: 403 521-3164
  • British Columbia
    • Kelowna, British Columbia, Canada, V1Y 5L3
      • Recruiting
      • BCCA - Kelowna
      • Contact: Katie Jasper; Phone Number: 250 712-3900
    • Prince George, British Columbia, Canada, V2M 7E9
      • Recruiting
      • BCCA - Prince George
      • Contact: Andre Gouveia
    • Vancouver, British Columbia, Canada, V5Z 4E6
      • Recruiting
      • BCCA - Vancouver
      • Contact: Leah Lambert; Phone Number: 604 877-6000
    • Victoria, British Columbia, Canada, V8R 6V5
      • Recruiting
      • BCCA - Victoria
      • Contact: Caroline Holloway; Phone Number: 250 519-5609
  • New Brunswick
    • Saint John, New Brunswick, Canada, E2L 4L2
      • Recruiting
      • Regional Health Authority B, Zone 2
      • Contact: Anthony J. Reiman; Phone Number: 506 648-6884
  • Ontario
    • Kingston, Ontario, Canada, K7L 2V7
      • Recruiting
      • Kingston Health Sciences Centre
      • Contact: April Swoboda; Phone Number: 613 544-2361
    • Toronto, Ontario, Canada, M4N 3M5
      • Recruiting
      • Odette Cancer Centre
      • Contact: Amandeep Taggar; Phone Number: 2804 416 480-6165
  • Quebec
    • Québec, Quebec, Canada, G1S 4L8
      • Recruiting
      • CHA-Hopital Du St-Sacrement
      • Contact: Claudya Morin; Phone Number: 418 682-7511
  • Saskatchewan
    • Regina, Saskatchewan, Canada, S4T 7T1
      • Recruiting
      • Allan Blair Cancer Centre
      • Contact: Ayesha Bashir; Phone Number: 306 766-2691
    • Saskatoon, Saskatchewan, Canada, S7N 4H4
      • Recruiting
      • Saskatoon Cancer Centre
      • Contact: Shahid Ahmed; Phone Number: 306 655-2710

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

This study is designed to include participants who have consented to a CCTG clinical trial. If a patient consents to a CCTG trial but does not enroll, they will remain eligible for SC.32S.

Description

Inclusion Criteria:

• Adults (≥18 years) who are either:

  • Currently being screened and consented to a CCTG trial (prospective).
  • Already enrolled in an ongoing CCTG trial and still under follow-up (retrospective).

Exclusion Criteria:

• Participants already enrolled or expected to enroll in a CCTG trial that is also collecting the SDoH Questionnaire.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial	12 months

Secondary Outcome Measures

Outcome Measure	Time Frame
To assess the acceptability of this SDoH questionnaire to participants.	12 months

Collaborators and Investigators

• Sponsor: Canadian Cancer Trials Group
• Investigators: Study Chair: Leah Lambert, BCCA - Vancouver Cancer Centre, Vancouver, BC Canada; Study Chair: Michael McKenzie, BCCA - Vancouver Cancer Centre

Study record dates

Study Major Dates

• Study Start (Actual): May 15, 2026
• Primary Completion (Estimated): January 31, 2027
• Study Completion (Estimated): June 30, 2027

Study Registration Dates

• First Submitted: January 29, 2026
• First Submitted That Met QC Criteria: January 29, 2026
• First Posted (Actual): February 5, 2026

Study Record Updates

• Last Update Posted (Actual): August 11, 2026
• Last Update Submitted That Met QC Criteria: August 10, 2026
• Last Verified: June 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms
• Other Study ID Numbers: SC32S

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: As per CCTG policy.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No